World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Research Report 2024 (covering USA, Europe, China, Japan, India, South East Asia and etc)

Publication ID:

ICRW03190797

Publication Date:

March 19, 2019

Pages:

107

Publisher:

ICRW

Countries:

Global [1]

USD 2,960.00

Pharmacy [2]

Healthcare [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

Summary
Chronic Kidney Disease (CKD) Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Chronic Kidney Disease (CKD) Drugs 麻豆原创: Product Segment Analysis
Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction
Hypocalcemia: Calcium supplements and possibly calcitriol
Hyperparathyroidism: Calcitriol or vitamin D analogues
Anemia: Iron replacement therapy and erythropoiesis-stimulating agents
Global Chronic Kidney Disease (CKD) Drugs 麻豆原创: Application Segment Analysis
Hospital use
Clinic use
Household
Global Chronic Kidney Disease (CKD) Drugs 麻豆原创: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Johnson & Johnson
Abbott Laboratories
F. Hoffmann-La Roche
Takeda Pharmaceuticals
Actavis
Akebia Therapeutic
Raptor Pharmaceuticals
Rockwell Medical
AMAG Pharmaceuticals
Sanofi
Reata Pharmaceuticals
Cara Therapeutics
FibroGen

Table Of Contents:

Table of Content

Chapter 1 About the Chronic Kidney Disease (CKD) Drugs Industry
1.1 Industry Definition and Types
1.1.1 Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction
1.1.2 Hypocalcemia: Calcium supplements and possibly calcitriol
1.1.3 Hyperparathyroidism: Calcitriol or vitamin D analogues
1.1.1.4 Anemia: Iron replacement therapy and erythropoiesis-stimulating agents
1.2 Main 麻豆原创 Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World 麻豆原创 Competition Landscape
2.1 Chronic Kidney Disease (CKD) Drugs 麻豆原创s by Regions
2.1.1 USA
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.1.2 Europe
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.1.3 China
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.1.4 India
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.1.5 Japan
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.1.6 South East Asia
麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Sales and Growth Rate 2014-2024
Major Players Revenue (M USD) in 2018
2.2 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 by Types
Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction
Hypocalcemia: Calcium supplements and possibly calcitriol
Hyperparathyroidism: Calcitriol or vitamin D analogues
Anemia: Iron replacement therapy and erythropoiesis-stimulating agents
2.3 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 by Applications
Hospital use
Clinic use
Household
2.4 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Analysis
2.4.1 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Revenue and Growth Rate 2014-2018
2.4.2 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Consumption and Growth rate 2014-2018
2.4.3 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Price Analysis 2014-2018

Chapter 3 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 share
3.1 Major Production 麻豆原创 share by Players
3.2 Major Revenue (M USD) 麻豆原创 share by Players
3.3 Major Production 麻豆原创 share by Regions in 2018, Through 2024
3.4 Major Revenue (M USD) 麻豆原创 share By Regions in 2018, Through 2024

Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material 麻豆原创 Analysis
4.2.1 Raw material Prices Analysis 2014-2018
4.2.2 Raw material Supply 麻豆原创 Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users 麻豆原创 Analysis

Chapter 5 Company Profiles
5.1 Johnson & Johnson
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 Abbott Laboratories
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 F. Hoffmann-La Roche
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 Takeda Pharmaceuticals
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Actavis
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Akebia Therapeutic
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Raptor Pharmaceuticals
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 Rockwell Medical
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 AMAG Pharmaceuticals
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Sanofi
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Reata Pharmaceuticals
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Cara Therapeutics
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 FibroGen
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 麻豆原创ing strategy
6.4 Barriers to Entry

Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India

Chapter 9 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Forecast through 2024
9.1 World Chronic Kidney Disease (CKD) Drugs Demand by Regions Forecast through 2024
9.2 World Chronic Kidney Disease (CKD) Drugs Price(by Regions, Types, Applications)Analysis Forecast through 2024
9.3 World Chronic Kidney Disease (CKD) Drugs Revenue (M USD)(by Regions, Types, Applications) Forecast through 2024
9.4 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Analysis
9.4.1 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Revenue and Growth Rate 2014-2018
9.4.2 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Consumption and Growth rate 2014-2018
9.4.3 World Chronic Kidney Disease (CKD) Drugs 麻豆原创 Price Analysis 2014-2018

Chapter 10 Key success factors and 麻豆原创 Overview

Tables and figures
Table Main 麻豆原创 Activities by Regions
Table 麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Table Major Players Revenue (M USD) in 2018
Table 麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Table Major Players Revenue (M USD) in 2018
Table 麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Table Major Players Revenue (M USD) in 2018
Table 麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Table Major Players Revenue (M USD) in 2018
Table 麻豆原创 Revenue (M USD) and Growth Rate 2014-2024
Table Major Players Revenue (M USD) in 2018
Table Major Production 麻豆原创 share by Players 2018
Table Major Revenue (M USD) 麻豆原创 share by Players 2018
Table Production 麻豆原创 share by Major Regions in 2014-2018
Table Production 麻豆原创 share by Major Regions in 2018-2024
Table Revenue (M USD) 麻豆原创 share by Regions in 2014-2018
Table Revenue (M USD) 麻豆原创 share by Regions in 2018-2024
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2014-2018
Table Raw material Suppliers 麻豆原创 Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Johnson & Johnson Information List
Figure Chronic Kidney Disease (CKD) DrugsChronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Johnson & Johnson
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Johnson & Johnson 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Johnson & Johnson 2018-2018
Table Abbott Laboratories Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Abbott Laboratories
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Abbott Laboratories 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Abbott Laboratories 2018-2018
Table F. Hoffmann-La Roche Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of F. Hoffmann-La Roche
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of F. Hoffmann-La Roche 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of F. Hoffmann-La Roche 2018-2018
Table Takeda Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Takeda Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Takeda Pharmaceuticals 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Takeda Pharmaceuticals 2018-2018
Table Actavis Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Actavis
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Actavis 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Actavis 2018-2018
Table Akebia Therapeutic Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Akebia Therapeutic
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Akebia Therapeutic 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Akebia Therapeutic 2018-2018
Table Raptor Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Raptor Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Raptor Pharmaceuticals 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Raptor Pharmaceuticals 2018-2018
Table Rockwell Medical Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Rockwell Medical
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Rockwell Medical 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Rockwell Medical 2018-2018
Table AMAG Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of AMAG Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of AMAG Pharmaceuticals 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of AMAG Pharmaceuticals 2018-2018
Table Sanofi Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Sanofi
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Sanofi 2018-2018
Table Reata Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Reata Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Reata Pharmaceuticals 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Reata Pharmaceuticals 2018-2018
Table Cara Therapeutics Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Cara Therapeutics
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cara Therapeutics 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of Cara Therapeutics 2018-2018
Table FibroGen Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of FibroGen
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of FibroGen 2018-2018
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World 麻豆原创 Share of FibroGen 2018-2018
Table Business Locations
Figure Supply channels
Figure 麻豆原创ing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Price by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Price by Types Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Price by Applications Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Revenue (M USD) by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Revenue (M USD) by Types Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)
Table World Revenue (M USD) by Applications Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2018-2024)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.